Highlights Include:
Time: 2:00 pm
day: Pre-Conference Workshop Day
Details:
- Exploring early detection and identification of pulmonary fibrosis
- Comparing inflammatory and fibrotic ILD data
- Highlighting the role of immune cells in ILD and fibrosis
- Unlocking IPF as the key to succeed in other types of ILD by capturing the translatability of therapeutics
- Investigating ILD biomarkers to understand trial populations
- Identifying endpoints which are likely to predict clinical success
- Considering when resolution of inflammation goes wrong
- Understanding the RA-ILD biomarkers, genetics, proteomics, and therapeutics currently available
- Cultivating effective therapeutics that reflect the unique patient populations of interstitial lung disease
